Insider and congress filings
Bio-Techne Corporation (TECH)
About Bio-Techne Corporation
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- Kim Kelderman
- Employees
- 3,000
- Listed since
- Feb 9, 1989
- Market value
- $11.3B
- Price to earnings
- 61.8
- Earnings per share
- $1.17
- Dividend yield
- 0.44%
Earnings
6 reported quarters · next on Nov 4, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Aug 12, 2026 | $0.52 | $0.52 | $321.2M | $314.6M | EPS in lineRevenue beat |
| Q3 FY2026reported May 6, 2026 | $0.53 | $0.55 | $311.4M | $316.1M | EPS missRevenue in line |
| Q2 FY2026reported Feb 4, 2026 | $0.46 | $0.43 | $295.9M | $290.5M | EPS beatRevenue beat |
| Q1 FY2026reported Nov 5, 2025 | $0.42 | $0.42 | $286.6M | $291.3M | EPS in lineRevenue miss |
| Aug 6, 2025 | $0.53 | $0.50 | $317.0M | $314.6M | EPS beatRevenue in line |
| Q3 FY2025reported May 7, 2025 | $0.56 | $0.51 | $316.2M | $317.2M | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Sep 19, 2025| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Kim KeldermanPresident and CEO | $936K | $3.9M | $3.3M | $8.2M |
| James HippelExecutive Vice President and CFO | $723K | $4.5M | $1.9M | $7.0M |
| William GeistPresident, Protein Sciences | $573K | $1.2M | $1.4M | $3.1M |
| Matthew McManusPresident, Diagnostics and Spatial Biology | $572K | $1.2M | $1.1M | $2.8M |
| Shane BohnenSenior Vice President and General Counsel | $431K | $768K | $782K | $2.0M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $990.9M | 14,025,816 | +14.4% | 8.99% |
| FMR LLC | $904.0M | 12,794,784 | +62.0% | 8.20% |
| Vanguard Capital Management LLC | $721.9M | 10,218,558 | +0.4% | 6.55% |
| Goldman Sachs Group Inc | $518.8M | 7,343,324 | +277.8% | 4.71% |
| HBK Investments L P | $482.2M | 6,825,000 | +100.0% | 4.38% |
| Vanguard Portfolio Management LLC | $459.7M | 6,506,360 | +0.4% | 4.17% |
| Morgan Stanley | $450.4M | 6,374,717 | -25.3% | 4.09% |
| State Street Corp | $422.5M | 5,980,370 | +1.9% | 3.83% |
| Geode Capital Management, LLC | $377.5M | 5,351,464 | +4.7% | 3.43% |
| Invesco Ltd. | $352.3M | 4,986,424 | +8.7% | 3.20% |
| Ruane, Cunniff & Goldfarb L.P. | $236.6M | 3,348,841 | -1.3% | 2.15% |
| Snyder Capital Management L P | $223.5M | 3,163,816 | +68.1% | 2.03% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
1 filing of 335 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Amy E. HerrDirector | Sold | 6,636 | $48.28 | $320K | May 8, 2026 | 4d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in TECH
20 disclosures of 42 on record · median 25d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +45.2%S&P +0.4% · vs S&P 500 +44.8% | Jun 2, 2026 | Jul 6, 2026 | 34d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +2.3%S&P +2.1% · vs S&P 500 +0.2% | Jun 30, 2026 | Jul 6, 2026 | 6d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +66.9%S&P +3.2% · vs S&P 500 +63.7% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +25.6%S&P +11.1% · vs S&P 500 +14.5% | Apr 13, 2026 | May 11, 2026 | 28d |
| April McClain DelaneyDependent child | Stock | Sale | $1,001 - $15,000 | +30.9%S&P +13.0% · vs S&P 500 +18.0% | Apr 8, 2026 | May 6, 2026 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +38.8%S&P +20.7% · vs S&P 500 +18.2% | Mar 30, 2026 | Apr 7, 2026 | 8d |
| April McClain DelaneyDependent child | Stock | Sale | $1,001 - $15,000 | +37.2%S&P +18.0% · vs S&P 500 +19.2% | Mar 26, 2026 | Apr 6, 2026 | 11d |
| April McClain DelaneyDependent child | Stock | Sale | $1,001 - $15,000 | +25.5%S&P +11.0% · vs S&P 500 +14.5% | Feb 24, 2026 | Mar 10, 2026 | 14d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +12.9%S&P +9.8% · vs S&P 500 +3.1% | Jan 29, 2026 | Feb 6, 2026 | 8d |
| April McClain DelaneyDependent child | Stock | Sale | $1,001 - $15,000 | +10.3%S&P +9.8% · vs S&P 500 +0.5% | Jan 28, 2026 | Feb 2, 2026 | 5d |
| April McClain DelaneyDependent child | Stock | Purchase | $1,001 - $15,000 | +17.2%S&P +11.3% · vs S&P 500 +5.9% | Dec 5, 2025 | Jan 5, 2026 | 31d |
| April McClain DelaneyDependent child | Stock | Purchase | $1,001 - $15,000 | +14.8%S&P +12.0% · vs S&P 500 +2.8% | Dec 2, 2025 | Jan 5, 2026 | 34d |
| April McClain DelaneyDependent child | Stock | Purchase | $1,001 - $15,000 | +13.3%S&P +14.3% · vs S&P 500 -1.0% | Oct 22, 2025 | Nov 4, 2025 | 13d |
| April McClain DelaneyDependent child | Stock | Sale | $1,001 - $15,000 | +31.7%S&P +22.8% · vs S&P 500 +8.9% | Aug 1, 2025 | Sep 2, 2025 | 32d |
| April McClain DelaneyDependent child | Stock | Sale | $1,001 - $15,000 | +48.5%S&P +29.2% · vs S&P 500 +19.3% | May 26, 2025 | Jul 2, 2025 | 37d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +46.6%S&P +28.2% · vs S&P 500 +18.4% | May 19, 2025 | Jun 10, 2025 | 22d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +50.7%S&P +29.7% · vs S&P 500 +21.0% | May 28, 2025 | Jun 10, 2025 | 13d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | +26.0%S&P +35.9% · vs S&P 500 -9.9% | Apr 1, 2025 | May 14, 2025 | 43d |
| Robert Bresnahan | Stock | Sale | $1,001 - $15,000 | +48.2%S&P +54.2% · vs S&P 500 -6.0% | Apr 8, 2025 | May 8, 2025 | 30d |
| April McClain DelaneyDependent child | Stock | Purchase | $1,001 - $15,000 | +33.7%S&P +40.7% · vs S&P 500 -6.9% | Apr 9, 2025 | May 2, 2025 | 23d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
2 members · estimate, as of Sep 10, 20262 members report a position (estimated). The largest estimated position is in the $1,001 - $15,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Julie Johnson | Democrat · House | $1,001 - $15,000 | 0.1% |
| April McClain Delaney | Democrat · House | $1,001 - $15,000 | 0.1% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| William GeistPresident, Protein Sciences | Stock award | 38,747 | Aug 17, 2026 |
| Steven C. CrousePresident - Diag & Spatial Bi | Stock award | 22,842 | Aug 17, 2026 |
| Kim KeldermanChief Executive Officer | Stock award | 151,172 | Aug 17, 2026 |
| Shane BohnenSVP - General Counsel | Stock award | 29,776 | Aug 17, 2026 |
| James HippelCFO | Stock award | 58,897 | Aug 17, 2026 |
| Amy E. HerrDirector | Stock award | 1,381 | Aug 17, 2026 |
| Kim KeldermanChief Executive Officer | Disposed to issuer | 55,548 | Aug 15, 2026 |
| James HippelCFO | Option exercise | 19,558 | Aug 15, 2026 |
| James HippelCFO | Tax withholding | 4,310 | Aug 15, 2026 |
| James HippelCFO | Disposed to issuer | 47,981 | Aug 15, 2026 |
| William GeistPresident, Protein Sciences | Option exercise | 12,832 | Aug 15, 2026 |
| William GeistPresident, Protein Sciences | Tax withholding | 1,976 | Aug 15, 2026 |
| William GeistPresident, Protein Sciences | Disposed to issuer | 31,405 | Aug 15, 2026 |
| Shane BohnenSVP - General Counsel | Option exercise | 8,700 | Aug 15, 2026 |
| Shane BohnenSVP - General Counsel | Tax withholding | 1,343 | Aug 15, 2026 |
| Shane BohnenSVP - General Counsel | Disposed to issuer | 16,619 | Aug 15, 2026 |
| Steven C. CrousePresident - Diag & Spatial Bi | Option exercise | 10,846 | Aug 15, 2026 |
| Steven C. CrousePresident - Diag & Spatial Bi | Tax withholding | 1,947 | Aug 15, 2026 |
| Amy E. HerrDirector | Option exercise | 1,178 | Aug 15, 2026 |
| Amy E. HerrDirector | Tax withholding | 213 | Aug 15, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling TECH?
Across the one open-market filing shown here, 0 were purchases and 1 was a sale.
Which members of Congress have traded TECH?
Ro Khanna, April McClain Delaney, Julie Johnson, Robert Bresnahan disclosed TECH transactions in the filings shown here.
Which members of Congress hold TECH?
2 members of Congress report a position in TECH in the estimate we hold as of Sep 10, 2026. The two largest estimated positions belong to Julie Johnson and April McClain Delaney. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is TECH in the S&P 500 or the Nasdaq 100?
Bio-Techne Corporation is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are TECH trades disclosed?
Insider filings on this page reached the public a median of 4 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.